Estimation of salivary sialic acid in oral premalignancy and oral squamous cell carcinoma
- PMID: 27994410
- PMCID: PMC5141657
- DOI: 10.4103/0976-237X.194108
Estimation of salivary sialic acid in oral premalignancy and oral squamous cell carcinoma
Abstract
Aims: Oral cancer is the most life-threatening disease of oral tissues. In societies where the incidence of oral cancer is high, clinically recognizable premalignant lesions are particularly common. Diagnosing oral cancers at an early stage is critical in improving the survival rate and reducing the morbidity associated with the disease. Alterations in the sialic acid levels in cancer patients have stimulated interest in this sugar residue as a possible tumor marker.
Settings and design: The purpose of this study was to estimate the salivary sialic acid levels in patients with oral premalignancy and squamous cell carcinoma and to correlate it with their grades to develop a cost-effective and noninvasive diagnostic parameter.
Materials and methods: Unstimulated whole saliva was collected from the groups under study and subjected to biochemical analysis for determination of sialic acid levels.
Statistical analysis used: The salivary sialic acid levels were correlated with the clinical stage and histological grade by one-way ANOVA (SPSS software version 15).
Results: Salivary sialic acid was elevated in oral squamous cell carcinoma (OSCC) compared to oral premalignancy and control group. A statistically significant correlation was observed between the grades of squamous cell carcinoma, grades of dysplasia in premalignancy, and sialic acid level.
Conclusion and clinical significance: Evaluation of salivary sialic acid levels in premalignant and malignant lesions can serve as a screening tool. The mortality and morbidity of OSCC can be reduced if the lesions are diagnosed in early precancerous states using such noninvasive diagnostic methods for screening and monitoring of the population.
Keywords: Leukoplakia; oral squamous cell carcinoma; saliva; sialic acid.
Conflict of interest statement
There are no conflicts of interest.
Figures




Similar articles
-
Total sialic acid, total protein and total sugar levels in serum and saliva of oral squamous cell carcinoma patients: A case control study.Dent Res J (Isfahan). 2013 May;10(3):343-7. doi: 10.4103/1735-3327.115155. Dent Res J (Isfahan). 2013. PMID: 24019802 Free PMC article.
-
Evaluation of salivary sialic acid, total protein, and total sugar in oral cancer: a preliminary report.Indian J Dent Res. 2008 Oct-Dec;19(4):288-91. doi: 10.4103/0970-9290.44529. Indian J Dent Res. 2008. PMID: 19075429
-
Usefulness of salivary sialic acid as a tumor marker in tobacco chewers with oral cancer.J Cancer Res Ther. 2020 Apr-Jun;16(3):605-611. doi: 10.4103/jcrt.JCRT_337_19. J Cancer Res Ther. 2020. PMID: 32719275
-
Relevance of serum and salivary sialic acid in oral cancer diagnostics.J Cancer Res Ther. 2020 Apr-Jun;16(3):401-404. doi: 10.4103/jcrt.JCRT_512_19. J Cancer Res Ther. 2020. PMID: 32719243 Review.
-
Salivary Metabolomics for Oral Squamous Cell Carcinoma Diagnosis: A Systematic Review.Metabolites. 2022 Mar 26;12(4):294. doi: 10.3390/metabo12040294. Metabolites. 2022. PMID: 35448481 Free PMC article. Review.
Cited by
-
Is Salivary Sialic Acid a Reliable Biomarker in the Detection of Oral Potentially Malignant Disorder and Oral Squamous Cell Carcinoma.J Maxillofac Oral Surg. 2021 Mar;20(1):83-89. doi: 10.1007/s12663-019-01309-7. Epub 2019 Nov 20. J Maxillofac Oral Surg. 2021. PMID: 33584047 Free PMC article.
-
Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches.Front Oncol. 2019 Nov 1;9:1143. doi: 10.3389/fonc.2019.01143. eCollection 2019. Front Oncol. 2019. PMID: 31737570 Free PMC article. Review.
-
Expression of 9-O-Acetylated Sialic Acid in HPV+ Oral Squamous Cell Carcinoma Cells.Life (Basel). 2025 Apr 17;15(4):663. doi: 10.3390/life15040663. Life (Basel). 2025. PMID: 40283217 Free PMC article.
-
Ratio of Salivary Sialic Acid to Fucose as Tumor Markers in Potentially Malignant Disorders and Oral Cancer.Contemp Clin Dent. 2020 Apr-Jun;11(2):131-135. doi: 10.4103/ccd.ccd_336_20. Epub 2020 Aug 7. Contemp Clin Dent. 2020. PMID: 33110325 Free PMC article.
-
"Salivary LINC00657 and miRNA-106a as diagnostic biomarkers for oral squamous cell carcinoma, an observational diagnostic study".BMC Oral Health. 2023 Dec 12;23(1):994. doi: 10.1186/s12903-023-03726-0. BMC Oral Health. 2023. PMID: 38087258 Free PMC article.
References
-
- Shpitzer T, Bahar G, Feinmesser R, Nagler RM. A comprehensive salivary analysis for oral cancer diagnosis. J Cancer Res Clin Oncol. 2007;133:613–7. - PubMed
-
- Rajpura KB, Patel PS, Chawda JG, Shah RM. Clinical significance of total and lipid bound sialic acid levels in oral pre-cancerous conditions and oral cancer. J Oral Pathol Med. 2005;34:263–7. - PubMed
-
- Scully C, Sudbø J, Speight PM. Progress in determining the malignant potential of oral lesions. J Oral Pathol Med. 2003;32:251–6. - PubMed
-
- Massano J, Regateiro FS, Januário G, Ferreira A. Oral squamous cell carcinoma: Review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:67–76. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources